MarketInOut Stock Screener Log In | Sign Up
 

Axogen Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 08/12/2026 16:00
Axogen Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,606.36 mln
Float50.35 mln
Earnings Date11/10/2026

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.76
Likely reliable

1-Year Forecast

53.22
Modest upside

Relative Strength

87 / 100
Strongly outperforming

Debt / Equity

0.08
Debt-free

ROE

-19.44
Negative

Business Description

Axogen is a global medical company focused on helping patients recover from peripheral nerve damage through a range of surgical repair products and techniques. Its portfolio includes processed nerve grafts, protective implants, and soft tissue solutions designed to support surgeons in reconnecting and healing injured nerves. The company serves hospitals, surgical centers, and military medical facilities, working with plastic, orthopedic, hand, and oral surgeons through a network of independent distributors. Based in Alachua, Florida, Axogen manages the full process of bringing its nerve repair products to market, from donor tissue recovery and processing to final sterilization and packaging.

Key Fundamentals

EPS-0.67
ROE-19.44
RPS5.01
ROIC-7.91
ROA-13.55
EBITDA, mln-20.30
EV / EBITDA-104
EV / EBIT-71.74
Revenue, mln251
EV / Revenue8.39

Financial Strength

Altman Z-Score29.08
Piotroski F-Score 6 / 9
Beneish M-Score-2.76
Price to Graham Number10.21
1-Year Target Price53.22
Short Ratio2.99
Short % of Float8.75

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 9.84% 90 / 100   
1 Month 28.11% 96 / 100   
2 Months 13.56% 83 / 100   
6 Months 43.93% 91 / 100   
1 Year 255% 98 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us